DEI in Clinical Trials: Current Initiatives and the Impact of the FDA Guidance on Cell and Gene Therapy Trials
Time: 11:30 am
day: Day 1
Details:
- Assessment of current initiatives employed to improve clinical trial diversity
- Current challenges and barriers for patients, PIs, and life science executives
- Impact of FDA guidance on pharma and biotech organizations
- Guidance on what tactics are the most likely to be impactful to improve trial diversity
- Special considerations for ensuring cell and gene therapy trial diversity
